CTOs on the Move

ProMetic

www.prometic.com

 
ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparation, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.prometic.com
  • 440 Boul. Armand-Frappier Suite 300
    Laval, QC CAN H7V 4B4
  • Phone: 450.781.0115

Executives

Name Title Contact Details

Funding

ProMetic raised $30M on 03/01/2016

Similar Companies

Twin Boro Physical Therapy

With 42 locations in 10 New Jersey counties, Twin Boro Physical Therapy could not be more convenient! Our skilled physical therapists match the proper techniques with each patients ailment and body.

Pharmascent

Pharmascent is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PRC

PRC is a global leader in AAC Solutions including for individuals with speech disorders. *This group does not provide official technical support.

Servier Pharmaceuticals

Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients` lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes.

Design Therapeutics

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions.